Thursday, May 23, 2019 7:30:44 AM
BioElectronics has great potential and we are focusing our limited resources on the key areas.
The CVS sale was a test as part of store remolding program. Our product did very well without an advertising and promotional campaign. We have been included for evaluation by another chain. It’s the strength of the product.
Our focus right now is on the following:
• FDA market clearance for musculoskeletal pain for the entire body and relief of postoperative pain which will also cover chronic wounds.
• Rebuilding our sales in the UK behind the counter at higher margins.
• Recruiting marketing partners for ActiPatch®, Footcare, and the wraps and sleeve market.
• Actively discussing with an international pharmaceutical company product distribution internationally and the US orthopedic market.
We will be more communicative in the future.
Regards,
Andrew J. Whelan
President
BioElectronics Corporation
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM